INCIDENCE OF ACUTE PANCREATITIS WITH THE USE OF IMMUNE CHECKPOINT INHIBITORS (ICI) IN SOLID TUMORS : A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
George, John
Yoo, Jin Woo
Joshi, Nikhil
Farrell, James J.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1236
引用
收藏
页码：S714 / S714
页数：1
相关论文
共 50 条
  • [21] The role of immune checkpoint inhibitors (ICI) as adjuvant treatment in renal cell carcinoma (RCC): A systematic review and meta-analysis
    Monteiro, Fernando Sabino Marques
    Soares, Andrey
    Rizzo, Alessandro
    Santoni, Matteo
    Mollica, Veronica
    Grande, Enrique
    Massari, Francesco
    CLINICAL GENITOURINARY CANCER, 2023, 21 (03) : 324 - 333
  • [22] Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis
    Yang, Ping
    Shen, Guoshuang
    Zhang, Hengheng
    Zhang, Chengrong
    Li, Jinming
    Zhao, Fuxing
    Li, Zitao
    Liu, Zhen
    Wang, Miaozhou
    Zhao, Jiuda
    Zhao, Yi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [23] Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Jiang, Yi
    Zhang, Ning
    Pang, Hailin
    Gao, Xiaobo
    Zhang, Helong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 293 - 302
  • [24] Steroid-refractory immune checkpoint inhibitor (ICI) hepatitis and ICI rechallenge: A systematic review and meta-analysis
    Hwang, Soo Young
    Hsieh, Pinghsin
    Zhang, Wei
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (10)
  • [25] Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Liu, Caihong
    Wei, Wei
    Yang, Letian
    Li, Jian
    Yi, Cheng
    Pu, Yajun
    Yin, Ting
    Na, Feifei
    Zhang, Ling
    Fu, Ping
    Zhao, Yuliang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study
    Bogani, Giorgio
    Cinquini, Michela
    Signorelli, Diego
    Pizzutilo, Elio G.
    Romano, Rebecca
    Bersanelli, Melissa
    Raggi, Daniele
    Alfieri, Salvatore
    Buti, Sebastiano
    Bertolini, Federica
    Bonomo, Pierluigi
    Marandino, Laura
    Rizzo, Mimma
    Monteforte, Marta
    Aiello, Marco
    Tralongo, Antonio C.
    Torri, Valter
    Di Donato, Violante
    Giannatempo, Patrizia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 187
  • [27] The efficacy and safety of solid tumors combination therapy with immune checkpoint inhibitor: A systematic review and meta-analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    ANNALS OF ONCOLOGY, 2018, 29
  • [28] The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S928 - S929
  • [29] Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta-Analysis
    Xu, Huijun
    Yang, Yang
    Yan, Ying
    Li, Mengge
    Wu, Shusheng
    Cao, Lulu
    Chen, Wenju
    Luo, Huiqin
    He, Yifu
    CANCER MEDICINE, 2024, 13 (20):
  • [30] Predictors of response to immune checkpoint inhibitors (ICI) rechallenge post-disease progression in solid tumors: A systematic review and meta-analyses
    Abushukair, Hassan Mohammed
    Al-Kraimeen, Leen Mohammad
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345